EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Generative AI in Drug Discovery: From Molecular Design to Translational Impact
Generative AI is changing how scientists think about drug discovery Rather than searching existing compound libraries or modifying known scaffolds these models can propose chemical ideas under defined constraints
-
Techno Trends
Salanersen Receives FDA Breakthrough Status for Spinal Muscular Atrophy
Biogen has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen an investigational treatment for spinal muscular atrophy SMA
-
Projects
Siemens Invests $14 Million in Drummondville Plant Expansion to Advance Digital Manufacturing
Siemens Canada has completed a major expansion and modernisation project at its manufacturing facility in Drummondville Qubec The yearlong project represents an investment of approximately US million
-
Research Insights
Thymidylate synthase inhibitory drugs induce p53-dependent pathways differently
Thymidylate synthase TS is a key enzyme in thymidylate biosynthesis and an established target of chemotherapeutics such as fluorodeoxyuridine FdUR and raltitrexed RTX Inhibition of TS disrupts
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
B2B Pharmaceutical Marketing in the USA: Strategies, Channels, and Emerging Trends
Kate Williamson
The B2B pharmaceutical marketing in the USA requires a balanced approach of compliance, credibility and business. This article discusses the effective pharma B2B, the various marketing channels, how t...
-
2
The Future of Quality Control: ML Applications in Pharmaceuticals
Kate Williamson
This article explores the transformative impact of machine learning (ML) applications on quality control in the pharmaceutical industry. It delves into areas such as enhanced data analysis, adaptive q...
-
3
From Qubits to Proteins: Quantum Computing's Promise in Protein Folding
Vidya Niranjan
Quantum computing's fusion with biochemistry ushers a new era of scientific exploration, offering breakthroughs in pharmaceuticals. This article explores quantum mechanics' role in protein fol...
-
4
What Challenges and Opportunities Define Modern CNS Drug Development?
Kate Williamson
The landscape of modern CNS drug development is marked by challenges including CNS complexity, BBB limitations, disease heterogeneity, biomarker scarcity, safety concerns, limited treatments, regulato...
-
5
The Procedure of Pharmaceutical Development
Xiaoya Zhang
Pharmaceutical development is the identification and evaluation of cycles needs to change over a functioning drug fixing into a medication item reasonable for its expected reason. In the beginning pha...
press releasesRead more...
Shed and LTR Pharma Execute Definitive Commercial Agreement to Bring ROXUS® to Patients Across the United States
Shed has announced the execution of a definitive commercial agreement with LTR Pharma formalizing the companies partnership to commercialize ROXUS LTR Pharmas rapidonset intranasal treatment for erectile dysfunction
Oath Surgical Performs First Outpatient Robotic Prostatectomy in the U.S. Pacific Northwest
Oath Surgical today announced the successful completion of the first robotic prostatectomy performed in an outpatient surgery center in the US Pacific Northwest The procedure performed at Oaths surgery center in Beaverton
Fuse Oncology Launches FuseRx, Closing the Gap Between Consult and Treatment in Radiation Oncology
Fuse Oncology the structured AI platform for radiation oncology today announced the launch of FuseRx a prescribing and treatmentintent solution for radiation oncology FuseRx will make its public debut
Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer
Oncolytics Biotech Inc a clinicalstage immunotherapy company today announced that the US Food and Drug Administration FDA has granted Fast Track designation to pelareorep in combination
Events Read more...
20 - 22
Jul 20266th mRNA-Based Therapeutics Summit
The Westin Boston Seaport Dist...
20 - 22
Jul 2026Liquid Biopsy for Precision Oncology Summit
Boston, MA, USA
24 - 25
Jul 2026Cardiovascular Medicine Pharmacology 2026
Paris, France
26 - 30
Jul 2026ADLM 2026
Anaheim, CA USA
27 - 28
Jul 2026Pharmacovigilance & Drug Safety 2026
Rome, Italy
27 - 28
Jul 2026Pharmacology 2026
Rome, Italy
27 - 28
Jul 2026PharmaSci Innovations 2026
Rome, Italy
28 - 30
Jul 20265th In Vivo Cell & Gene Summit 2026
500 Commonwealth Avenue, Bosto...
LATEST NEWSRead more...
Myriad Genetics Launches FirstGene Multiple Prenatal Screen
Myriad Genetics has announced the full commercial launch of the FirstGene Multiple Prenatal Screen a laboratory test that combines four prenatal genetic screening tests into a single blood sample collected as early
BREZTRI Now Available in the US for Asthma Patients Aged 12 and Older
AstraZeneca has announced that BREZTRI AEROSPHERE is now commercially available by prescription in the United States for the maintenance treatment of asthma in adults and children aged years and older
Revvity Launches ‘Signals for Startups’ to Support Early-Stage Biotech Companies
Revvity has introduced Signals for Startups a new programme designed to help earlystage biotechnology companies establish scalable digital informatics capabilities from the beginning of their research and development activities
Lupin Spins Out Two Oncology Programmes to Kaveri Therapeutics
Lupin has announced the strategic spinout of two oncology programmes LNP PRMT and LNP SOS into Kaveri Therapeutics a USbased clinicalstage oncology company
FDA grants traditional approval to Novartis' Fabhalta for primary IgA nephropathy
Novartis has announced that the US Food and Drug Administration FDA has granted traditional approval to Fabhalta iptacopan for slowing kidney function decline in adults with primary immunoglobulin A nephropathy
Illumina Expands Billion Cell Atlas Programme with New AI Drug Development Partners
Illumina has expanded its Billion Cell Atlas programme by adding three new member companies including AInative drug developer Formation Bio to support the development of nextgeneration therapies
